BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
企業コードBGLC
会社名BioNexus Gene Lab Corp
上場日Mar 11, 2020
最高経営責任者「CEO」Mr. Lee Su-Leng Tan
従業員数30
証券種類Ordinary Share
決算期末Mar 11
本社所在地10-2 Tower B, Vertical Business Suite
都市KUALA LUMPUR
証券取引所NASDAQ Capital Market Consolidated
国Malaysia
郵便番号59200
電話番号13072416898
ウェブサイトhttps://www.bionexusgenelab.com/
企業コードBGLC
上場日Mar 11, 2020
最高経営責任者「CEO」Mr. Lee Su-Leng Tan
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし